About Cureos
Cureos is a Healthcare company based in Delhi (India) founded in 2020 by Siddhartha Nautiyal. A chain of clinics focused on diabetes care is operated. Cureos has raised $280.34 thousand across 1 funding round from investors including Amit Ahuja, Dharmendra Kumar Rao and Amit Ahuja. Cureos was last valued at $1.4 million in February 2020. Its focus areas include Clinic Chains, Specialty Clinics, Endocrinology and Diabetes. Its legal entity in India is Rxos Healthcare Private Limited (U24299DL2020PTC359964). Its competitors include Dr. Mohan’s Diabetes Specialities Centre, Apollo Sugar and Lifespan; 1 of its 3 listed competitors has raised funding.
Company details
Cureos was founded in 2020 and is based in Delhi, India. Operations are centered on a network of clinics dedicated to diabetes management and care. Services encompass routine check-ups, treatment plans, and patient education in the healthcare sector. The company is led by co-founder and COO Siddhartha Nautiyal, with activities primarily serving the Indian market through its domain cureos.in.
- Headquarters Delhi, India
- Founders Siddhartha Nautiyal
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cureos.in
- Social LinkedIn Facebook
- Legal Name Rxos Healthcare Private Limited
- Date of Incorporation 08 Jan, 2020
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹8,778
FY 2023 · -98% YoY
- Net Loss-₹63,922
FY 2023 · -728% margin
- EBITDA-₹63,922
FY 2023 · -728% margin
- Total Equity Funding$280.34K (USD)
in 1 rounds
- Latest Funding Round$280.34K (USD), Angel Round
Feb 2020
Associated legal entities of Cureos
Cureos operates through Rxos Healthcare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rxos Healthcare Private Limited CIN U24299DL2020PTC359964 | Active | 08 Jan 2020 | New Delhi, Delhi | ₹0.0 Cr | 3 | View details |
Funding Insights of Cureos
Cureos has successfully raised a total of $280.34K through 1 strategic funding round. The most recent funding activity was a Angel Round of $280.34 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $280,335
- Total Rounds 1
- Last Round Angel Round — $280,335
- First Round $280,335
(Feb 2020)
- Investors Count 4
All 1 funding rounds of Cureos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2020 | $280,335 | Angel Round | $1.4M | Amit Ahuja, Dharmendra Kumar Rao | – |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2020 | $1.4M | •••••••• |
Last known valuation $1.4M (Feb 2020). 4 investors in total: 0 institutional and 4 angel.
Investors in Cureos
Cureos has secured backing from 4 investors, including angel investors. Prominent investors backing the company include Amit Ahuja, Dharmendra Kumar Rao and Amit Ahuja.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AA Amit Ahuja | Angel investor and entrepreneur, focused on tech startups, ex-Cisco executive | unknown_2035ece2754447308 | ||
DK Dharmendra Kumar Rao | unknown_c2b1eda1235b4af7a | |||
AA Amit Ahuja | unknown_54d6062c6ee14d0c8 | |||
DR Dharmendra Rao | unknown_99083df8034f4545b |
Investor details for Cureos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Rxos Healthcare Private Limited (Cureos)
Rxos Healthcare Private Limited is the primary company behind Cureos. The board of Rxos Healthcare Private Limited currently have 3 directors; the longest-serving is Yogesh Sharma, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Yogesh Sharma DIN 06534691 | Director | 08 Jan 2020 | 6 yrs 9 mo | Rxos Healthcare Private Limited |
| Siddhartha Nautiyal DIN 08662667 | Director | 08 Jan 2020 | 6 yrs 9 mo | Rxos Healthcare Private Limited |
| Manish Kumar Mahesheka DIN 08001555 | Director | 08 Jan 2020 | 6 yrs 9 mo | Rxos Healthcare Private Limited |
People of Cureos
1 people are tracked at Cureos (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & COO | Leadership |
Complete people profiles for Cureos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cureos
Figures of Rxos Healthcare Private Limited, the primary company behind Cureos, for FY 2023. Revenue was ₹8,778 (-98% year on year). Net loss was -₹63,922 (-728% margin). EBITDA was -₹63,922 (-728% margin).
- ₹8,778Revenue · FY 2023 · -98% YoY
- -₹63,922Net loss · -728% margin
- -₹63,922EBITDA · -728% margin
- ₹12 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Rxos Healthcare Private Limited are on its company page.
Detailed financial statements for Cureos
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Cureos
3 dated milestones of Cureos, from founding to its latest funding, stage changes and deals.
- Founded Cureos is founded.
- Funding First funding round of $280K.
- Milestone Reaches Minicorn status.
Competitors of Cureos
Cureos has 3 listed competitors in our database, 1 of them funded. They include Dr. Mohan’s Diabetes Specialities Centre, Apollo Sugar and Lifespan.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| drmohans.com | 2012 | Chennai, India | $10.17M | 971 | Chain of diabetes speciality centre | |
| apollosugar.com | 2014 | Delhi, India | 101 | Apollo Sugar runs a chain of clinics focused on diabetes management and treatment. | ||
| lifespanindia.com | 2011 | Mumbai, India | Chain of diabetes & cardio metabolism clinics |
Detailed competitors of Cureos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Cureos (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 4,459 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 8,400 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cureos
Cureos was founded in 2020.
Cureos is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Cureos is a funded company, having raised a total of $280.34K across 1 funding round to date. The company's 1st funding round was a Angel Round of $280.34K, raised on Feb 2020.
The primary company behind Cureos, Rxos Healthcare Private Limited, reported revenue of ₹8,778 for FY 2023, down 98% year on year.
Cureos was founded in 2020 and is based in Delhi, India. Operations are centered on a network of clinics dedicated to diabetes management and care. Services encompass routine check-ups, treatment plans, and patient education in the healthcare sector. The company is led by co-founder and COO Siddhartha Nautiyal, with activities primarily serving the Indian market through its domain cureos.in.
Cureos's top competitors include Dr. Mohan’s Diabetes Specialities Centre, Apollo Sugar and Lifespan.
Cureos has 4 investors. Key investors include Amit Ahuja, Dharmendra Kumar Rao, Amit Ahuja, and Dharmendra Rao.
The valuation of Cureos is $1.4M as of Feb 2020.
Cureos operates through Rxos Healthcare Private Limited.
The legal entities of Cureos currently have 3 directors, including Yogesh Sharma, Siddhartha Nautiyal, Manish Kumar Mahesheka.